Immutep Ownership

PRRUF Stock  USD 0.20  0.00  0.00%   
Immutep Limited has a total of 879.09 Million outstanding shares. Immutep retains 4.61 (percent) of its outstanding shares held by insiders and 24.04 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Immutep in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Immutep, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Immutep Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Immutep Pink Sheet Ownership Analysis

About 24.0% of the company shares are owned by institutional investors. The book value of Immutep was at this time reported as 0.11. The company recorded a loss per share of 0.02. Immutep Limited had not issued any dividends in recent years. The entity had 1:10 split on the 5th of November 2019. Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. Immutep Limited was incorporated in 1987 and is headquartered in Sydney, Australia. Immutep operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for Immutep Limited is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Immutep Limited contact Marc Voigt at 61 2 8315 7003 or learn more at https://www.immutep.com.

Currently Active Assets on Macroaxis

Other Information on Investing in Immutep Pink Sheet

Immutep financial ratios help investors to determine whether Immutep Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Immutep with respect to the benefits of owning Immutep security.